+91-8591768159  |    info@heyanhealth.com   Book Free Demo
Call Us WhatsApp Book Demo
Evidence-Based Medicine

Clinically Proven.
Globally Validated.

Backed by peer-reviewed publications from ACC, JACC, and ESC — and validated for the Indian population in the Indian Heart Journal.

View Publications Download Clinical Summary
99.2% ECG Quality Agreement
98.7% MI Detection Sensitivity
500+ Patient Dataset (ESC 2023)
6 International Publications
Clinical Evidence

Science You Can Stand Behind

DILasa is not just a product — it's a clinically validated medical device with peer-reviewed evidence from the world's top cardiac bodies. Every claim we make is backed by published research, prospective patient studies, and international conference recognition.

ACC ACC.20 JACC JACC 2022 ESC ESC 2022 · 2023 · 2024 Indian Heart Journal
Peer-Reviewed Evidence

Published Research & Conference Recognition

Six international publications and presentations spanning 2020 to 2024.

ACC.20 — American College of Cardiology

Wearable ECG Vest: Non-Inferior Signal Quality

Prospective study in 150 patients comparing wearable ECG vest electrode placement against standard clinical electrode placement. Study design: randomised crossover, blinded signal quality analysis.

Key Finding: 99.2% ECG quality agreement with standard placement — non-inferior by pre-specified margin.
JACC — Journal of the American College of Cardiology

Operator-Independent 12-Lead ECG Acquisition via Pre-Positioned Electrode Vest

Published in JACC 2022. Full-length original research article demonstrating clinical-grade ECG acquisition without any operator training, using the pre-positioned electrode vest system.

Key Finding: Zero training required for clinical-grade ECG acquisition. Operator error eliminated by design.
ESC Congress 2022 — European Society of Cardiology

Late-Breaking Trial Session Recognition

DILasa was presented at the ESC Congress 2022 Late-Breaking Trial session — the most competitive and high-visibility track at the world's largest cardiology congress, attended by over 30,000 cardiologists.

Recognition: Top 10 Innovation Posters at ESC Congress 2022.
ESC Congress 2023 — European Society of Cardiology

Follow-Up Data: 500+ Patient Dataset

Follow-up data from expanded multi-centre deployment presented at ESC Congress 2023. Dataset of 500+ patients across diverse demographics, comorbidities, and body habitus profiles.

Key Finding: Confirmed reliability across diverse patient populations including elderly, obese, and post-cardiac event cohorts.
ESC Congress 2024 — European Society of Cardiology

Real-World Deployment Data: 15 Clinics, 3 States

Real-world deployment data presented from active clinic installations across 15 clinics in 3 Indian states. Analysis of operational efficiency, patient throughput, and clinician satisfaction.

Key Finding: Average scan time: 28 seconds in real-world clinical environments — consistent with controlled trial results.
Indian Heart Journal

Indian Population Validation Study

Dedicated validation study in an Indian patient cohort of 200 patients. Focused on performance for myocardial infarction (MI) detection — the highest-stakes use case for rapid ECG deployment.

Key Findings: Sensitivity 98.7% & Specificity 97.3% for MI detection in Indian population.
Intellectual Property & Grants

Protected. Funded. Recognised.

Indian Patent — Granted

Method and Device for Rapid 12-Lead ECG Acquisition Using Pre-Positioned Electrode Vest

Status: Granted — Indian Patent Office
Grant Date: July 15, 2025
Patent No: [Pending Publication]
Applicant: Heyan Health Solutions Pvt Ltd
Scope: Device design, electrode positioning method, and signal acquisition protocol for wearable 12-lead ECG vest.

Patent protects the core innovation from competitors. Full details available post publication in Indian Patent Journal.
₹50 Lakhs — BIRAC BIG Grant

BIRAC BIG Grant — ₹50 Lakhs

Funding Body: Biotechnology Industry Research Assistance Council (BIRAC)
Ministry: Department of Biotechnology, Government of India
Grant Purpose: Development and commercialisation of DILasa wearable ECG device
Category: Biotechnology Ignition Grant (BIG) — for validated MedTech innovations with commercialisation potential

BIRAC selection validates DILasa's scientific merit, commercial potential, and public health impact. Only ~3% of applicants receive the BIG grant.
Clinical Resources

Download Clinical Summary PDF

Get a consolidated summary of all published validation data, trial outcomes, and performance benchmarks — formatted for clinical and procurement decision-makers.

Access the Clinical Summary

Please provide your details below. We'll verify your access and enable the download immediately — no waiting, no spam.

Your information is kept confidential and used only to process your download request. We do not share data with third parties.

Access Granted

Your clinical summary is ready. Click below to download.

Download Clinical Summary PDF

File size: ~2.4 MB | PDF format

What's in the Clinical Summary?

Trial Results Summary Tabulated data from all 6 publications including sensitivity, specificity, and ECG quality metrics.
Patient Population Details Demographics, comorbidities, and inclusion/exclusion criteria from each study.
Regulatory & Grant Milestones BIRAC grant details, patent grant status, and CDSCO filing timeline.
Real-World Deployment Data Performance metrics from 15 clinic deployments across 3 Indian states.
Clinician Quotes & Case Studies Direct feedback from deploying cardiologists and GPs on clinical utility.

Used By: Procurement teams at hospital networks, insurance companies evaluating technology, government scheme committees, and international distributors evaluating India market entry.

Next Step

Convinced? Book a Clinical Demonstration.

See DILasa perform a 12-lead ECG in under 30 seconds — live, at your facility. No commitment required.

Book a Clinical Demo Product Details